Effect of Sitagliptin on Progression of Coronary Intermediate Lesion

Status:
Completed

Trial end date:
2017-03-10

Target enrollment:

Participant gender:

This study was to investigate the Effect of Sitagliptin, a dipeptidyl peptidase-4 inhibitor, on Progression of Coronary Intermediate Lesion.

Phase 4

Li Bo

Sitagliptin Phosphate